Autolus Therapeutics
ISIN US05280R1005
Autolus Therapeutics has no current public net short positions above the disclosure threshold. The last disclosure was by Henderson Global Investors Limited of 0.43% on 2024-02-12, reported to BaFin.
Total net short positions over time
Previous position holders
No current positions above the disclosure threshold. Most recent disclosures per holder:
- Henderson Global Investors Limited0.43%2024-02-12
Data is sourced from Bundesanstalt für Finanzdienstleistungsaufsicht, which publishes net short position disclosures on its public, free-to-access website. ShortsInsights.com republishes this information for convenience and may apply formatting, grouping, and cleaning that can introduce differences from the source. Data may be delayed, incomplete, or inaccurate, and may not reflect the most recent filings or corrections.
ShortsInsights.com is provided "as is" for informational purposes only and does not constitute investment, legal, or other advice. Users should verify any information directly with Bundesanstalt für Finanzdienstleistungsaufsicht before making decisions. ShortsInsights.com and its operators disclaim liability for errors, omissions, or actions taken in reliance on the information to the fullest extent permitted by law.